News

Porter discusses regulatory compliance, ATMP sponsors, and Philadelphia’s Cellicon Valley.

New initiative to be named Robert A. Winn Diversity in Clinical Trials Award Program.

Expansion of services to meet increasing demand from industry.

New partnership brings AiCure solutions to Italy.

WCG's suite of clinical trial solutions will be made available to a wider range of CROs.

Neurology model will help power real-world evidence generation into the rare-disease patient journey.

Newly combined organization to provide pharmacovigilance solution focused on current and future requirements of the life sciences industry.

Specialty area to focus on major depression, schizophrenia, multiple sclerosis, and more.

Regulatory bodies in Europe offer guidance for sponsors in light of recent events.

With Veeva Development Cloud, Boehringer Ingelheim aims to accelerate the development of novel medicines.

New monitoring and recording technology will further compliment existing library of DCT, ePRO tools.

Collaboration on new AI-driven technology will enhance THREAD's existing platform.

Will bridge critical gaps in care for people of color with moderate to severe plaque psoriasis.

Data demonstrates efficacy of smart dosing technology.

Industry must act now to minimize effects of COVID-19 on clinical research.

AMCR to utilize ScienceMedia's protocol compliance management solution.

Platform to alleviate logistical challenges with patients.

FDA recently approved the disease-modifying therapy for adults with hemolytic anemia caused by PK (pyruvate kinase) deficiency.

New white paper assess implications of technology on DCTs.

Almost 5% of global drugs trials are conducted in Ukraine and Russia and are now on hold.

Calyx brings medical Imaging, IRT, and EDC solution delivery to ProTrials customers.

15.6M DKK will be used to bring trials closer to patients in Denmark.

FDA compliant operating system to deliver longitudinal health data and patient engagement.

The latest business and people happenings from the past month, all in one place.

Emmes bolsters rare disease research capabilities.

New collaboration will drive diversity in clinical trials.

New facilities and services to meet growing demand for Phase I studies.

MHRA shares CluePoints case study to demonstrate the value of statistical monitoring in clinical trial oversight and monitoring.